BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20493476)

  • 1. An assessment of the elastic properties of the aorta in nonobese women with polycystic ovary syndrome.
    Kaya MG; Gunebakmaz O; Zencir C; Yilmazsoy A; Karadag M; Topsakal R; Ergin A; Kelestimur F
    Fertil Steril; 2010 Nov; 94(6):2402-5. PubMed ID: 20493476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries.
    Lakhani K; Hardiman P; Seifalian AM
    Atherosclerosis; 2004 Aug; 175(2):353-9. PubMed ID: 15262192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity--but not a PCOS-associated phenomenon.
    Ketel IJ; Stehouwer CD; Henry RM; Serné EH; Hompes P; Homburg R; Smulders YM; Lambalk CB
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4566-75. PubMed ID: 20660051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
    Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
    Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with increased carotid intima-media thickness and being nondipper in nonobese and normotensive young patients affected by PCOS.
    Ercan EA; Ertek S; Is G; Caglar O; Oztas E; Cicero AF; Alhan A; Cehreli S; Tore HF; Erdogan G
    Angiology; 2011 Oct; 62(7):543-8. PubMed ID: 21733949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter.
    Gullu H; Erdogan D; Caliskan M; Tok D; Yildirim E; Ulus T; Turan Sezgin A; Muderrisoglu H
    Echocardiography; 2006 Nov; 23(10):835-42. PubMed ID: 17069601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
    Kaya C; Pabuccu R; Berker B; Satiroglu H
    Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
    Soares GM; Vieira CS; Martins WP; Franceschini SA; dos Reis RM; Silva de Sá MF; Ferriani RA
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):406-11. PubMed ID: 19094071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
    Kaya MG; Calapkorur B; Karaca Z; Yildirim S; Celik A; Akpek M; Unluhizarci K; Kelestimur F
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):885-92. PubMed ID: 22563947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.
    Talbott EO; Zborowski JV; Boudreaux MY; McHugh-Pemu KP; Sutton-Tyrrell K; Guzick DS
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6061-7. PubMed ID: 15579759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
    Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome.
    Trakakis E; Balanika A; Baltas C; Loghis C; Simeonidis G; Vaggopoulos V; Papakonstantinou O; Gouliamos A; Salamalekis G; Kassanos D
    J Endocrinol Invest; 2008 Nov; 31(11):1001-7. PubMed ID: 19169057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ideal cardiovascular health in adolescence: effect of lifestyle intervention and association with vascular intima-media thickness and elasticity (the Special Turku Coronary Risk Factor Intervention Project for Children [STRIP] study).
    Pahkala K; Hietalampi H; Laitinen TT; Viikari JS; Rönnemaa T; Niinikoski H; Lagström H; Talvia S; Jula A; Heinonen OJ; Juonala M; Simell O; Raitakari OT
    Circulation; 2013 May; 127(21):2088-96. PubMed ID: 23613255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients.
    Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Yilmaz C
    Int J Immunogenet; 2009 Oct; 36(5):283-8. PubMed ID: 19744034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.
    Adali E; Yildizhan R; Kurdoglu M; Bugdayci G; Kolusari A; Sahin HG
    Fertil Steril; 2010 Jul; 94(2):666-72. PubMed ID: 19368913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of urinary albumin excretion and metabolic complications in polycystic ovary syndrome.
    Caglar GS; Oztas E; Karadag D; Pabuccu R; Eren AA
    Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):57-61. PubMed ID: 20888116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to predict subclinical atherosclerosis in systemic lupus erythematosus.
    Zardi EM; Afeltra A
    Rheumatology (Oxford); 2011 May; 50(5):821-3. PubMed ID: 20819798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.